Yu Galaxy

Yu Galaxy is a venture capital firm founded in 2020 by P.R. Yu, focusing on early-stage investments in technology companies that aim to solve significant global issues. The firm emphasizes a mission-driven approach, partnering with visionary founders to develop products and services that have a measurable impact on society. Yu Galaxy's portfolio spans sectors such as healthcare, artificial intelligence, defense, and automation, reflecting its commitment to supporting innovations that address humanity's most pressing challenges.

The firm's investment strategy is characterized by conviction and speed, often engaging with founders at the seed stage and moving quickly to provide capital and support. This agility allows Yu Galaxy to back companies that are redefining industries and improving lives, with a focus on delivering both strong financial returns and positive social impact. Notable portfolio companies include Leo Cancer Care, Capstan Medical, and Wibotic, each contributing to advancements in their respective fields.

Yu Galaxy's philosophy centers on the belief that impact and profit are inseparable. By investing in companies that save lives, advance science, and protect the planet, the firm demonstrates that financial success and social good can go hand in hand. This approach has led to significant growth in the firm's assets under management, surpassing $500 million as of October 2025, underscoring the effectiveness of its lean, mission-driven model in the venture capital landscape.